Non-invasive prenatal diagnosis (NIPD) could significantly change the framework for testing
and screening in pregnancy. This chapter reviews the ethical implications of this technology …

BACKGROUND Huntington's disease (HD) is an autosomal dominant neurodegenerative
late onset disorder. This review of reproductive options aims to increase reproductive …

The 1994 predictive test guidelines for Huntington's disease (HD) were published by an ad
hoc Committee comprising representatives from the World Federation of Neurology (WFN) …

Non‐invasive prenatal testing (NIPT) is an emerging form of prenatal genetic testing that
provides information about the genetic constitution of a foetus without the risk of pregnancy …

This chapter first explains the incidence or prevalence of congenital anomalies or genetic
disorders. Many factors influence efforts to accurately determine the incidence or prevalence …

The possibilities of non-invasive prenatal testing (NIPT) are expanding, and the use of NIPT
for adult-onset conditions may become widely available in the near future. If parents use …

During the last decade, the field of human genome research has gone through a phase of
rapid discovery that has provided scientists and physicians with a wide variety of research …

Expanded non-invasive prenatal testing (NIPT) has provoked ethical concerns about its
justifiable scope. In this paper, we evaluate the role of the child's right to an open future in …

Research indicates that health care professionals' attitudes may affect patients' decisions
regarding prenatal Huntington Disease testing, but few studies have sampled genetic …

Huntington's disease (HD) is a severe neurodegenerative condition that impacts the whole
family. Prenatal diagnosis by direct or exclusion testing is available for couples at risk of …